Elevated c-Src and c-Yes expression in malignant skin cancers - Wikidata - awgldk - TriplyDB

Elevated c-Src and c-Yes expression in malignant skin cancers

Elevated c-Src and c-Yes expression in malignant skin cancers

http://www.wikidata.org/entity/Q34114252

about

Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo Predictive biomarkers for dasatinib treatment in melanoma.Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics c-Yes regulates cell adhesion at the apical ectoplasmic specialization-blood-testis barrier axis via its effects on protein recruitment and distribution.Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients Expression patterns of α2,3-sialyltransferase I and α2,6-sialyltransferase I in human cutaneous epithelial lesions.Immunotherapy in nonmelanoma skin cancer.Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.Antitumor activity of miR-1280 in melanoma by regulation of Src.Manganese superoxide dismutase-mediated inside-out signaling in HaCaT human keratinocytes and SKH-1 mouse skin.Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

P2860

Q31033276-EB5B4299-DFF6-4A65-B396-886634669085 Q34781153-2445BE40-909E-4CA3-BF38-9D8930EA2AA2 Q35618896-C9E1450C-1A6E-4B18-BC49-15940B222AC9 Q35889822-1FE37F2A-C353-40F0-A319-6A67551291C9 Q36104523-7E355302-B27C-4513-B9EF-E4AF23D39CBE Q36527756-D58CCFAA-300C-4CFB-834F-822E584D880C Q36718672-80124A2F-43B3-4C08-ADEB-38F8061C39F6 Q36783017-C5B2DEB4-593F-4123-A49C-DFFA3E734F52 Q36853436-BF19145C-0C2D-4195-9FEA-8430EAD2E34C Q36931879-3765CDE8-03ED-4434-B7C0-CCDB52ECD070 Q38014084-285C63A4-21DD-4258-A9BD-B4BA68B9AED7 Q38827105-525DFCBC-E7F5-4C50-B37E-56F84ACB3050 Q38959078-2E4E95BD-A9AB-43AA-92A3-9D39406ACD03 Q39014809-73DD2E1C-04E8-401B-BB54-F39F34CF642C Q42206973-0B37F7CF-54BB-4294-A24D-8FCB4A7FF3E7 Q54977387-01A9000D-C4AF-4D05-86D8-D14806DB2C23

P2860

Elevated c-Src and c-Yes expression in malignant skin cancers

http://www.wikidata.org/entity/Q34114252

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Elevated c-Src and c-Yes expression in malignant skin cancers

@ast

Elevated c-Src and c-Yes expression in malignant skin cancers

@en

Elevated c-Src and c-Yes expression in malignant skin cancers

@nl

type

label

Elevated c-Src and c-Yes expression in malignant skin cancers

@ast

Elevated c-Src and c-Yes expression in malignant skin cancers

@en

Elevated c-Src and c-Yes expression in malignant skin cancers

@nl

prefLabel

Elevated c-Src and c-Yes expression in malignant skin cancers

@ast

Elevated c-Src and c-Yes expression in malignant skin cancers

@en

Elevated c-Src and c-Yes expression in malignant skin cancers

@nl

P1433

Q34114252-670727B8-B917-46C9-9683-CF1972E795E3

P1476

Q34114252-05F220F1-163E-4080-831E-A5E8EC07CA8B

P2093

Q34114252-015F3E04-65A7-457A-B21E-17ED2A85152E

Q34114252-0D14A649-263D-48FB-A8C6-0598E2F92560

Q34114252-10A57257-171F-44EA-9BE9-0201095CA05A

Q34114252-4516E6E1-05C4-4F74-9363-1DE246BC3A6A

Q34114252-4576FC6E-BEDE-4AA5-857E-7E733955D7AE

Q34114252-8466B126-56C8-4D68-9F87-3FD2EDDD1969

Q34114252-A192CB53-F1D1-4B33-AE98-1ADFD7632D2A

Q34114252-A5EECEB6-1A0A-4D5A-A720-A37646210A6E

Q34114252-AC72000B-7A02-4075-B581-74614D00D7DE

Q34114252-D53A9669-3A50-4071-8DF8-145FDF970A70

P2860

Q34114252-0E19C338-88B6-4F76-A858-E7E72474FEF7

Q34114252-161F41E5-AD54-4B30-8453-9D45FD83E5EE

Q34114252-3798E310-B0DA-429A-917C-7189586FEFBC

Q34114252-5479B969-8EB5-4AF2-9250-AB4F998EC341

Q34114252-576CCDD5-E230-497D-ADBB-C62A303EAC3E

Q34114252-61687C22-DB1C-4580-94C0-FEAC924DBD74

Q34114252-7E2092BF-B61D-4FE0-9342-B44237CC06FF

Q34114252-9C793E5E-DFBC-4629-884E-DADB9765713B

Q34114252-AB859B83-AA66-44BD-8EF6-981A4FF07A00

Q34114252-C2287F7D-E9C4-40F2-8F3D-B066E45AB9B3

P2888

Q34114252-D3EC4C35-54B3-48B0-819E-921ECA0D7425

P304

Q34114252-AB8E76E9-311D-48ED-872C-0812D249E57A

P31

Q34114252-D933F2EB-C24C-4501-9257-4A9E35305C7D

P356

Q34114252-71E18542-08D3-4E87-8929-71270CA49D86

P478

Q34114252-994B230A-D530-42B1-A6D0-070AF4B7EC54

P577

Q34114252-343BA26E-2A32-4073-B080-F5B8A91DD8C1

P5875

Q34114252-8B85E0B3-F256-4AD6-8DC4-0F0FFFBAB168

P6179

Q34114252-0D5C7E13-E66D-418F-BCD1-28BDD20324A9

P698

Q34114252-9A63F1B1-CF2D-4619-A23D-87C9DEAD4447

P932

Q34114252-F3D8B9CE-7E2E-40E4-8BCE-713065C8E155

P356

1756-9966-29-116

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Elevated c-Src and c-Yes expression in malignant skin cancers

@en

P2093

Chul Han Kim

http://www.w3.org/2001/XMLSchema#string

Dong Jun Jeong

http://www.w3.org/2001/XMLSchema#string

Dong Wook Kim

http://www.w3.org/2001/XMLSchema#string

Hae Seon Nam

http://www.w3.org/2001/XMLSchema#string

Jae-Kyung Pyon

http://www.w3.org/2001/XMLSchema#string

Jang Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Mi Youn Park

http://www.w3.org/2001/XMLSchema#string

Moon Kyun Cho

http://www.w3.org/2001/XMLSchema#string

Sang Gue Kang

http://www.w3.org/2001/XMLSchema#string

Sang Han Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular functions regulated by Src family kinases

Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.

Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells.

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck.

Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.

Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma

Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.

Expression of the c-src protooncogene in human skin tumors.

P2888

1756-9966-29-116

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-9966-29-116

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46008564

http://www.w3.org/2001/XMLSchema#string

P6179

1047751459

http://www.w3.org/2001/XMLSchema#string

P698

20796316

http://www.w3.org/2001/XMLSchema#string

P932

2936336

http://www.w3.org/2001/XMLSchema#string